- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
189
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
189 companies
Tiansheng Pharmaceutical Group
Market Cap: CN¥1.6b
Engages in the pharmaceutical manufacturing and circulation activities.
002872
CN¥4.88
7D
-6.7%
1Y
30.1%
Brii Biosciences
Market Cap: HK$1.4b
Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.93
7D
-7.2%
1Y
77.1%
Chongqing Lummy Pharmaceutical
Market Cap: CN¥4.6b
Engages in the research and development, manufacture, and sale of pharmaceutical products in China.
300006
CN¥4.52
7D
0%
1Y
51.2%
Oramed Pharmaceuticals
Market Cap: US$98.4m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$2.40
7D
5.7%
1Y
0.4%
Guizhou Yibai Pharmaceutical
Market Cap: CN¥3.2b
Researches, develops, produces, and sells pharmaceutical products in China.
600594
CN¥4.08
7D
-5.3%
1Y
19.6%
Kintor Pharmaceutical
Market Cap: HK$1.1b
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.
9939
HK$2.48
7D
-8.1%
1Y
150.5%
Maravai LifeSciences Holdings
Market Cap: US$699.7m
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$2.72
7D
-3.2%
1Y
-66.4%
C21 Investments
Market Cap: CA$55.9m
An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.
CXXI
CA$0.52
7D
10.6%
1Y
73.3%
Dezhan Healthcare
Market Cap: CN¥8.6b
Engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.
000813
CN¥4.19
7D
-7.3%
1Y
56.9%